INTRODUCTION
============

Reference intervals (RIs) are widely used in the process of making a medical diagnosis, therapeutic management decision, or other physiological assessment. RIs are supposed to be established or verified for each analyte and specimen source in every clinical laboratory. In reality, however, very few laboratories or manufacturers carry out their own reference interval studies. Other laboratories and manufacturers refer to RIs from studies done a few decades ago, when both the analytical methods and life style of the population were very different. So it is a very important task to carefully establish RIs by the laboratory based on standard protocols. The Clinical and Laboratory Standards Institute (CLSI) published and updated a guideline^[@R1]^ for laboratories and manufactures to perform their own reference interval studies. IFCC/C-RIDL recently published 2 papers including a protocol and standard operation procedures (SOPs) for multicenter RI studies.^[@R2],[@R3]^ A serum panel with assigned values traceable to the reference measurement procedures (RMP) was introduced in the multicenter study. It is meant for the alignment of test results among laboratories and for promoting common use of RIs through standardization.^[@R4]^

In China, only 12.2% of all the laboratories use self-established RIs or verified RIs, others adopt RIs from reagent inserts or reference articles, according to the nationwide survey conducted in 2010.^[@R5]^ There are a few reports on RIs for Chinese population,^[@R6]--[@R9]^ but there have been few large population-based nationwide studies of RIs which adopt up-to-date research design and employ advanced statistical methods. Therefore, in 2013, we voluntarily chose to participate from China in the global RIs study coordinated by IFCC/C-RIDL. In this study, we organized and conducted a multicenter nationwide RI study for Chinese Han population using the protocol and SOPs^[@R2]^ provided by IFCC/C-RIDL. The study was aimed to: (1) explore possible regional differences in reference values of major analytes among cities in 6 provinces; (2) define RIs to be used nationwide for as many analytes as possible. In this manuscript, we describe the analytical results obtained from this first nationwide multicenter RI study in China for 28 commonly tested biochemical analytes, which adopted the scheme of centralized measurements, up-to-date statistical methods, and strict procedure for standardization.

METHOD
======

Ethics
------

This study was approved by the Ethics Committee of Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Science. Written informed consents were obtained from all participants prior to the study.

Selection of Reference Population
---------------------------------

### Source of Reference Population

A total of 3148 apparently healthy individuals were recruited from 6 cities covering wide areas of China, which represented regions of Northeast (Dalian), Northwest (Urumqi), North (Beijing), East (Shanghai), Southwest (Chongqing), and South (Guangdong). All the participants should be living in the city for at least 1 year. Sixty individuals were required for each sex and for every age group as 19 to 29, 30 to 39, 40 to 49, 50 to 64, except for the group of \>65 years, for which group 20 individuals were required. Therefore, the target number of subjects per region was 520 \[60 × 2 (sexes) × 4 (4 age groups)\] + 40 \[20 × 2 (sexes)\]. Please note that test results from those \>65 years of age were meant for analyses after worldwide accumulation of reference values and thus were not analyzed in this Chinese study.

### Exclusion Criteria

The exclusion criteria were determined based on the protocol provided by IFCC/C-RIDL.^[@R2]^ Every participant was required to complete the questionnaire form to judge the eligibility. The height, weight, and blood pressure were measured on site. The exclusion criteria were as follows:Presence of acute or chronic diseases which require medical intervention including: respiratory diseases, circulation system diseases, liver or kidney diseases, acute and chronic infections, metabolic and nutritional diseases, autoimmune diseases, endocrine diseases, hematological diseases, and malignant tumor.Febrile conditions or use of antibiotics in the past 2 weeks.History of being a hospital in-patient or seriously ill during the previous 4 weeks.Surgery in the past 6 months.Blood donation in the previous 3 months.Female participants who are pregnant, breastfeeding, or within 1 year after childbirthKnown carrier state for hepatitis B virus, hepatitis C virus, or human immunodeficiency virus.Blood pressure: systolic pressure ≥160 mm Hg or diastolic pressure ≥100 mm Hg.Body mass index (BMI) ≥ 28 or ≤18.5 kg/ m^2^.Excessive alcohol consumption (average alcohol consumption ≥75 g ethanol/day).

Laboratory Analysis
-------------------

### Sample Collection and Processing

Preparation for sampling, sampling and sample processing procedures were performed according to the IFCC/C-RIDL protocol.^[@R2]^ The participants were required to avoid excessive eating or drinking, unusual strenuous exercise within 3 days before the sampling, and sampling on the day after working a night shift.

After overnight fasting for 10 to 14 hours, with no water drinking 1 hour before and no smoking half an hour before, 9 mL blood was collected into tubes with serum separator gel (SST II, Becton-Dickinson, or Vacuette, Greiner Bio-One GmbH, Austria). At 15 to 30 min after sampling, the samples were centrifuged at 1200 g for 10 min at room temperature. The serum from each tube was promptly divided into 4 aliquots of 1 mL each, using well-sealed freezing containers, and was immediately stored at −80°C. The samples, packed in dry ice, were sent to the central laboratory in Beijing within 2 months except for those taken in Chongqing, which were tested by the another central laboratory located in Chongqing.

### Tests and Analyzers

Beckman Coulter reagents for AU series were used on AU5800 analyzers in clinical laboratories of Peking Union Medical College Hospital, Beijing, and Daping Hospital, Chongqing, which acted as the second central laboratory for this study. Twenty-eight items including total protein (TP), albumin (Alb), Urea, uric acid (UA), creatinine (CRE), total bilirubin (TBil), sodium (Na), potassium (K), chloride (Cl), calcium (Ca), inorganic phosphate (IP), glucose (GLU), total cholesterol (TC), triglycerides (TG), high-density lipoprotein (HDL)-cholesterol (HDL-C), low-density lipoprotein (LDL)-cholesterol (LDL-C), aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP), lactate dehydrogenase (LDH), γ-glutamyltransferase (GGT), creatine kinase (CK), amylase (AMY), lipase (LIP), ion (Fe), magnesium (Mg), transthyretin (TTR), and transferrin (Tf) were measured for each serum sample. The assay methods for the analytes and the manufacture stated traceability are listed in Supplemental Table 1.

### Quality Control and Traceability

Commercial controls with assigned values were used to monitor the quality of the test results. The results must be within acceptable range shown in the inserts. A mini panel of 5 sera from healthy individuals was prepared and measured in singleton on each day of measurement to monitor the stability of the assays.^[@R3]^

To evaluate the traceability and make comparison of the results from the 2 central laboratories, a panel of 40 sera prepared from healthy individuals provided by the IFCC/C-RIDL was measured in both centers.^[@R4]^ The panel was value assigned based on certified reference materials and equivalent value assigned sera^[@R3]^ for 21 analytes including TP, Urea, UA, CRE, TBil, Glu, TC, TG, HDL-C, LDL-C, Na, K, Cl, Ca, IP, ALT, AST, CK, GGT, Tf, and TTR.

Data Analyses
-------------

Multiple regression analysis (MRA) was performed to identify sources of variation (SVs) possibly influencing the test results,^[@R10]^ including region, sex, age, BMI, levels of cigarette smoking, daily alcohol consumption, and regular physical exercise with respective levels categorized into 4, 5, and 8 grades as follows: none, ≤250, 250 to 500, 500 \< pack × year; none, ≤12.5, 12.5 to 25, 25 to 50, 50\< g ethanol/day; none, 1 to 7 days/week. In the analysis of regional differences by use of dummy variables, Beijing was set as the reference region. A given explanatory variable was considered to be of practical importance when its standardized partial regression coefficient, which corresponds to the partial correlation coefficient (*r*~*p*~), was \>0.15, which corresponds to *P* ≈ 0.0 with the large data size around 1500.

Standard deviations (SD) attributable to 3 major SVs^[@R10]^ of test results: between-region (SD-reg), between-sex (SD-sex), between-age (SD-age), together with net between-individual (SD-btw-ind) were computed by 3-level nested ANOVA. The relative magnitude of each SD was expressed as the ratio of SD (SDR) over SD-btw-ind: SDR~sex~, SDR~age~, and SDR~reg~ for SD due to sex, age, and region, respectively. An SDR \> 0.3 was regarded as a guide to consider partitioning reference values by the SV.^[@R3],[@R10]^

The latent abnormal values exclusion (LAVE)^[@R10]^ method was applied as a method for secondary exclusion with Alb, UA, Glu, TG, LDL-C, HDL-C, AST, ALT, GGT, LDH, CK, and CRP set as the reference test items for judging the need for exclusion. Modified Box--Cox power transformation formula was used to transform reference values into the Gaussian distribution.^[@R10]^ The RI was first computed as the mean ± 1.96 × SD of the transformed reference values selected by the LAVE method, and then reverse transformed to the original scale. The 90% confidence intervals (CI) of the lower and upper limits of the RIs (LLs and ULs) were calculated by use of the bootstrap method through random resampling of the same dataset for 100 times. Making use of the procedure, both LLs and ULs were optimized by taking their averages of the repeatedly derived values.

RESULTS
=======

Profile of the Population
-------------------------

Age and sex distributions of the participants in the 6 cities are shown in Table [1](#T1){ref-type="table"}. The average age and SD of participants were 41.8 ± 14.1 (n = 1509) years for man and 42.2 ± 13.8 (n = 1639) years for woman. As a whole, male female ratio was almost equal (52.1% vs 47.9%). The BMI was 23.6 ± 2.9 (n = 1507) for man and 22.2 ± 2.8 (1639) for woman. 31.8% of the male participants were smokers whereas females seldom smoke. About 35% of participants had different levels of exercise and the ratios of those who do regular exercise were almost equal for both sexes. A total of 26.2% of the male participants had different levels of drinking whereas females seldom drink (Figure [1](#F1){ref-type="fig"}).
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Age and Sex Composition of the Participants From the 6 Cities of China
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![Distribution of drinking, smoking, and exercise levels of the reference population. Pie charts were made for each sex to show proportions of levels for 3 life-style habits.](medi-95-e2915-g002){#F1}

Traceability
------------

The serum panel results of Beijing were compared to the assigned values and the results of Chongqing. The results of the comparison is shown in Supplemental Figure 1; as correlation matrix graphs made from assigned values, and test results from Beijing and Chongqing for each analyte. Urea, UA, TBil, CRE, Glu, TG, Na, K, Cl, Ca, IP, CK, Tf, and TTR were regarded as traceable to the RMP based on the comparison of Beijing\'s results with the assigned values.

The results of Chongqing were converted to those of Beijing by using the major axis regression line when the coefficient of variation (CV) of the regression line slope, CV(b), was below the critical value of 5.5%.^[@R4]^ The results for the analyte were judged convertible and merged except for those of Na, Cl, Mg, and TBil. The failure of the latter 4 analytes was attributed to the narrow coverage of the test ranges by the serum panel. However, the SD ratio (SDR) representing between-laboratory differences computed by use of the 1-way analysis of variance^[@R3]^ were 0.24, 0.09, 0.44, 0.14, respectively for the analytes, and thus their results except Mg were merged without conversion (Supplemental Table 2; Mg test results from Chongqing were not included in derivation of the RI.

The major axis linear regression between the assigned values and merged values of Chongqing to Beijing was used to assess the need for recalibration of test results.^[@R4]^ When difference in the lower or upper limit of the RI before and after recalibration was \>1/4 of SD of the original RI, recalibration of test results was performed by using regression coefficients (intercepts and slopes). This criterion corresponds to Frasers' allowable limit of bias. By this criterion, the recalibration based on the assigned values was performed for TP, GGT, TC, HDL-C, and LDL-C.

Regional Variations of Reference Values
---------------------------------------

The MRA results in Table [2](#T2){ref-type="table"}  showed that test results for Glu from Beijing were higher than those from other cities except Chongqing with *r*~*p*~ \< −0.15. Dalian showed a largest negative shift. We could not identify the reason, but the time between sampling and serum separation was carefully controlled to be identical. Both males and females of Hangzhou had a significantly high level of Na, and Guangzhou had a high level of UA, compared to Beijing. Males of Urumqi had a significantly high level of ALT than other 5 cities. Males of Chongqing and Urumqi both had much higher GGT than other cities. Though MRA results (*r*~*p*~) of LIP, Mg, K, and Cl were above 0.15, we considered the actual difference are very small and not of practical importance (Table [3](#T3){ref-type="table"}).
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MRA Results for Sources of Variation of Reference Intervals in Males and Females
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Regional Difference of Reference Intervals
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Age- and Sex-Related Changes of Results
---------------------------------------

Age-related changes were analyzed by combination of MRA and 3-level nested ANOVA (Table [4](#T4){ref-type="table"}), and 1-dimensional scattergrams (Figure [3](#F3){ref-type="fig"}). We observed that 5 analytes changed significantly with age in both sexes: Alb, LDL-C, TC, TG, and Urea. Alb steadily decreased with age, especially in males, and others increased. ALP, AMY, CK, Fe, GGT, Glu, LDH, and TG increased with age only in females. In males, the level of lipids increased mainly until the age of 40, whereas in female, the increase occurred more prominently after 40 years of age. The level of SDRs for sex (SDR~sex~) was significantly high (≥0.30) for 13 analytes: ALT, AST, CK, CRE, Fe, GGT, HDL-C, IP, TBil, TG, TTR, UA, and Urea.
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Sex-, Region-, and Age-Related Changes Evaluated by 3-Level Nested ANOVA
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Other Sources of Variations of the Results
------------------------------------------

MRA results (Table [2](#T2){ref-type="table"} ) revealed that test results for 7 analytes (UA, TG, HDL, ALT, GGT, CK, and AMY) in females and 10 analytes (UA, TC, TG, HDL-C, LDL-C, ALT, GGT, CK, AMY, TTR) in males were related to BMI. Of all the related analytes, only HDL-C and AMY decreased with the increase of BMI. Alcohol-related changes for GGT and TTR, and smoking-related change in TP were observed in males. No appreciable changes in test results in association with exercise level were noted in any analyte in both sexes.

Reference Intervals
-------------------

RIs were derived both parametrically (P) and nonparametrically (NP) with LAVE (−), LAVE (allowing 1 abnormal value), and LAVE (allowing no abnormal value). Most analytes had generally identical RIs determined by both P and NP methods, except for TBil, Glu, TG, AST, ALT, GGT, CK, and LIP, the ULs of which were higher derived by NP than by the P method. We observed that the ULs of some analytes decreased significantly when stricter secondary exclusion criteria were applied. It was seen for Glu, TG, TC, HDL-C, LDL-C, AST, ALT, LDH, ALP, GGT, CK, and LIP in female. And in males, those analytes were UA, TG, TC, AST, ALT, LDH, CK, GGT, and LIP. Examples of the comparison of RIs for both males and females by P and NP methods with or without LAVE method are shown in Figure [2](#F2){ref-type="fig"}. Those for other analytes, see Supplemental Figure 2 and Supplemental Figure 3. As a general rule, we derived the RIs by use of the P method without applying the LAVE procedure for analytes whose RIs did not change much by the procedure, such as TP, TBil, Na, K, and Ca. On the other hand, for those analytes which are sensitive to the LAVE procedure, such as TG, AST, ALT, GGT, and CK, we adopted the RIs by use of P method with LAVE (abn = 1). We did not adopt RIs by LAVE (abn = 0), because it led to narrow RIs by too strict exclusion of individuals with latent diseases. The final RIs of this study and comparison with other studies are listed in Table [5](#T5){ref-type="table"}.

![Comparison of RIs derived by parametric (P) and nonparametric (NP) methods with or without latent abnormal values exclusion (LAVE) method. The RIs were derived in 6 ways: by P or NP method with LAVE (abn = 1) or LAVE (abn = 0) or without application of LAVE method, where abn = 1 or abn = 0 implies allowance of 1 or no abnormal result among reference test items in accepting each record for use in deriving the RI. Each horizontal bar represents the RI, and the vertical line in the center corresponds to the midpoint. The shades on both ends of the bar represent 90%CI for the limits of the RI predicted by the bootstrap method of 100 repetitive computations. The results for 4 representative analytes for males (M) and females (F) are shown in this figure. The same figures for all other analytes are available in Suppl Figure 2 for M and in Suppl Figure 3 for F. F = females, LAVE = latent abnormal values exclusion, M = males, NP = nonparametric, P = parametric, RI = reference intervals.](medi-95-e2915-g007){#F2}
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RIs Derived by a Parametric Method With or Without LAVE and Comparison With Those From Reagent Inserts and Other Studies
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DISCUSSION
==========

Traceability
------------

Judging from test results of the serum panel, Urea, TBil, UA, CRE, Glu, TG, Na, K, Cl, Ca, IP, CK, Tf, and TTR were regarded as traceable to the reference materials. The results of TP, GGT, TC, HDL-C, and LDL-C were recalibrated by use of the major axis linear regression^[@R4]^ based on test results for the serum panel which has assigned values for those analytes.^[@R3]^ Therefore, the RIs derived for them in this study are applicable to any Chinese laboratory as long as the assays are standardized and regional differences in test results do not exist. The serum panel results for ALT and AST were lower than the assigned values, it is considered to be lack of Pyridoxal-5-phosphate (P5P) in the reagent for the 2 items. As the values of Alb, TBil, Mg, Fe, LDH, ALP, AMY, and LIP of the serum panel were not assigned by IFCC/C-RIDL in this study, the results of these analytes should be regarded as Beckman AU-specific RIs.

Exclusion of Latent Diseases
----------------------------

When determining the RI, the first thing is to define reference individual as appropriately as possible in consideration of many properties which constitute the status of healthiness by consensus among the investigators. We asked a series of questions and measured the anthropometric parameters including BMI and blood pressure to exclude those who possibly possessed pathological conditions. However, we may still include a lot of individuals who have latent diseases, especially those of high prevalence among apparently healthy individuals in China such as metabolic syndrome and diabetes mellitus.^[@R11]--[@R13]^ The LAVE method, which depends on association of abnormal test results among test items affected by those diseases, is considered a good way to deal with such situation.^[@R10],[@R14],[@R15]^ By application of the LAVE method with the stricter criteria,^[@R3]^ ULs derived were lowered in both P and NP methods. At the same time, the gaps of the ULs between P and NP methods became narrower. This is because more and more abnormal results from individuals with latent diseases were removed by the stricter LAVE criteria.

Sources of Variations
---------------------

In conducting the study on RIs, another important aspect is to explore SVs of each test item. Age, sex, BMI, and region are considered the most important SVs. With the use of MRA and nested-ANOVA, we reconfirmed age- and sex-related variations in many of the common analytes. Though our multicenter study covered a wide area of China, no significant regional differences were discovered in most analytes, expect Na, UA, ALT, GGT, and Glu. Test results of Na were higher in Hangzhou, which may reflect higher consumption of salt in foods. The ULs of UA for both male and female from Guangzhou were much higher than other cities. It is consistent with the report that Guangzhou had a higher prevalence of hyperuricemia than other cities.^[@R16]^ Higher UL of ALT for Urumqi may be due to higher BMI compared to other areas. ULs of GGT for males in both Chongqing and Urumqi are high. In interpreting the deviation of their ULs, we have to note that GGT has a very skewed distribution and thus its 90% CI of the UL is much wider than other analytes when RIs were determined province by province using a small sample. Anyway, a higher daily consumption of alcohol may partially explain the high GGT in Chongqing. However, after adjustment of alcohol consumption by use of MRA, GGT is not so high (compared with Beijing) in Chongqing and Urumqi (Table [2](#T2){ref-type="table"} ).

The life habit such as smoking may be another important SV to affect the RIs. The relation of smoking, drinking, and exercise with RIs were analyzed. We confirmed alcohol-related changes for GGT, TTR, and smoking-related changes for TP in males.^[@R17],[@R18]^ No such relations were seen in females, which is obviously due to very low proportion of females with habits of smoking and drinking.

Once notable SVs were observed, it is important to determine its relative magnitude of variation associated with the SV in order to evaluate the necessity of developing separate RIs according to the source. Several methods, such as Harris--Boyd method,^[@R19]^ Lahti method,^[@R20]^ and Ichihara method^[@R18]^ have been proposed for use. We adopted the Ichihara method in this study, which depends on 1-way ANOVA or 2 or multilevel nested ANOVA. It computes the SD ratio (SDR), which is the SD due to a given factor divided by the SD~BI~, or SD due to between-individual variation. The guide value for considering the partition is SDR = 0.3, which corresponds to the allowable limit of bias (B~A~) in analytical system:^[@R3]^ that is, the ratio of allowable bias is B~A~/SD~TB~ ≤ 0.25, where SD~TB~ represents total biological SD (= SD~BI~ unadjusted for SD due to sex and age) and is generally larger than our SD~BI~. Thus, the ratio was raised to 0.30 in consideration of the general difference between SD~TB~ and SD~BI~. The ratio was regarded appropriate for most cases. However, actual scatter plots for comparing test results across provinces or for sex-specific age profiling of test results are of relevance in interpreting SDR and for deciding whether or not to partition reference values. For example, we observed a steady decline of Alb by increasing age with SDR~age~ = 0.55. However, actual difference of the RI between age-subgroups is slight. Similarly, the SDR~reg~ for K is 0.39, but actual between province differences are rather small and of no clinical significance. The same thing is true to TP, Na, and Cl. The common features of these special analytes are the narrow range of the RI for these test results, and thus SDR tends to be exaggerated by placing relatively smaller SD~BI~ (≈1/4th of the RI) in the denominator. Another example of need for caution in using SDR is the case of LDH. Although SDR~sex~ is 0.0, when SDR~age~ was computed for each sex separately, SDR~age~ is 0.51 for males and 0.11 for females. This implies that between-sex difference was masked due to the interaction of age on the analysis of sex-related change. Therefore, SDR~sex~ was computed after subgrouped by age at 50 years. Without partition at age of 50, 14 analytes (50%) have SDR~sex~ \> 0.3, whereas 18 analytes (64%) have SDR~sex~ \> 0.3 with age \<50 and only 8 analytes (29%) have SDR~sex~ \> 0.3 with age ≥50 (Table [4](#T4){ref-type="table"}).

In fact, there are multiple test items which showed differential effect of sex on age-related change, as shown in Figure [3](#F3){ref-type="fig"}. In males, nutritional markers (TG, TC, LDL-C, ALT, AST, and GGT) increased from 20 to 40 years of age and unchanged or decreased thereafter. This mode of change reflects life style change with age, whereas in females, they increased from 30 to 60 with steeper changes between 45 and 55. The steeper part is interpreted as reflecting hormonal changes pecular to females. These observations point to the importance of computing SDR~sex~ and SDR~age~ in multiple ways and interpreting the values in reference to the sex- and age-related profiles.

![Sex- and age-related profiles of reference values. Two-dimensional scattergrams are shown for 12 typical test items with higher SDR~sex~ and/or SDR~age~. Blue and red dots denote males and females, respectivey, all from individuals without any abnormal results in the reference test items. The central curves of both sexes were drawn by smoothly connecting median values, which were computed at each year-by-year moving age segment of 5-year spans. The outer curves on both sides of the centers represent those of the 2.5 and 97.5 percentiles. Horizontal yellow lines shown in the graphs for UA, Glu, TG, TC, HDL-C, and LDL-C represent clinical decision limits (CDLs) specified in clinical guidelines. CDLs = clinical decision limits, Glu = glucose, HDL-C = high-density lipoprotein-cholesterol, LDH = lactate dehydrogenase, LDL-C = low-density lipoprotein-cholesterol, SDR = standard deviations ratio, TC = total cholesterol, TG = triglycerides, UA = uric acid.](medi-95-e2915-g009){#F3}

In this study, the ULs of the RIs for TG, TC LDL-C, and UA are all higher than the clinical decision limits (CDLs),^[@R21],[@R22]^ although they became appreciably lowered by application of the LAVE method, which effectively reduced the influence of metabolic conditions. Further attempt of applying stricter exclusion criteria in the recruitment might match the RIs a little closer to the CDLs, but it makes *a prior* study of the RI impossible with difficulty of recruitment. Therefore, it is important to reduce the influence of latent disease, but we cannot make the ULs identical with the CDLs (Figure [3](#F3){ref-type="fig"}).

In fact, CDLs were determined by consensus among experts of the diseases targeted by the CDLs for early detection and intervention (based on clinical experiences and epidemiological study), whereas the RIs are determined from individuals with as many healthy attributes as possible so that they serve as references for the healthy status, but they are not meant for distinguishing the healthy from the disease. Therefore, the RIs of these items with known CDLs should not be confused with the RIs. The CDLs should be primarily used for judging the need for preventing or diagnosing the diseases, but the RIs are still necessary for use in other clinical situations which are unrelated to the CDL-associated diseases.

Comparison of RIs With Other Studies
------------------------------------

The RIs of CRE, TBil, K, AST, LDH, ALP, GGT, CK, and AMY showed great difference compared with those from the reagent inserts (Table [5](#T5){ref-type="table"}). So, laboratories should evaluate the clinical applicability of the RIs from reagent inserts before use.

The RIs of TP, Alb, Urea, CRE, TBil, Na, K, Cl, Ca, IP, MG, Fe, AST, ALT, LDH, ALP, and GGT are close to those from Health occupation standards of China,^[@R23]--[@R29]^ which were approved by the Ministry of Health P. R. China, whereas the RI of AMY is much lower than that from the standard, which may because that the results of AMY were not standardized in our study.

Compared to another multicenter study by Mu et al^[@R9]^ in China, which aimed at liver function tests, RIs of ALT for females, TBil, AST, and LDH are very close. ULs of ALT and GGT for males are a little higher in our study. This may be attributable to the different exclusion criteria. In Mu\'s study, those who consumed alcohol \>30 g/day and/or with fatty liver disease had been excluded, whereas in our study, alcohol consumption and fatty liver disease were not considered in the recruitment because of planned use of the LAVE method. There were ∼2.3% of the participants who consumed \>25 g/day in our study. But the UL of GGT for females in Mu\'s study (43U/L) is about 39% higher than that in our study, which is 31 U/L with LAVE (abn = 1). We get 43U/L by LAVE(−) method, which is the same as the one by Mu\'s study. From this finding, it can be said that the LAVE method is more appropriate than Mu\'s method when applied to those apparently healthy individuals.

The RI of TP differed much between Mu\'s and our studies. We found that the RIs from Turkey (66 − 82 g/L with Abbott Architect 8000),^[@R30]^ Saudi (62−77 g/L with Abbott Architect 16000), Hongkong (66−80 g/L with Roche Modular)^[@R8]^ are close to ours (65−79 g/L) whereas that from Shuo Yang\'s study(68−86 g/L with Roche Modular)^[@R7]^ is close to Mu\'s(67.9--85.1 g/L for 4 cities and 70.1−90.1 g/L for another 2 cities).

The RI of Alb in our study is lower than Mu\'s study. They used 3 different assay systems and the RIs differed with each other. The final RI was adjusted according to the results from the 3 assay systems. Among the 3 systems, RI from AU system (described as Olympus in the article) is ∼42−52 g/L, which is very close to ours (41−52 g/L). So it is important to have specific RI for each assay system.

As compared to Turkey\'s and Saudi Arabia\'s^[@R31]^ multicenter study which used the same protocol with us, the RIs of TP, Alb, CRE, Glu, Na, K, Cl, Ca, IP, and Mg, Fe, LDH, ALP, GGT are close with each other. Among the 3 countries, Turkey has a highest lipids level, and Saudi Arabia has the lowest ALT level, which appear to be mainly due to difference in ethnicity and life style, and partly due to diffences in assay systems.

In conclusion, this is the largest multicenter RI study in China involving 28 commonly measured tests aimed at adult population, which also is a part of global multicenter collaborative project for derivation of RIs. Age and sex differences were observed in many items and it was important to decide the need for partitioning RIs based on combined analysis of nested-ANOVA and sex and age profile of reference values. No regional differences of practical importance were observed in any of the test items. The LAVE method was indispensable to derive the RIs more appropriately by minimizing the influence of metabolic disorders.
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